SmileDirectClub Inc

SmileDirectClub Inc

Health CareHealth Care Equipment & Services
  • Price (USD)6.88
  • Today's Change0.21 / 3.15%
  • Shares traded115.00
  • 1 Year change-18.58%
  • Beta--
Data delayed at least 15 minutes, as of Jul 28 2021 21:00 BST.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Profile data is unavailable for this security.

About the company

SmileDirectClub, Inc. provides medical technology platform. The Company provides SmileCheck, which is a teledentistry platform for doctor monitoring and communication. The Company provides clear aligner therapy treatment through its teledentistry platform. Its aligner treatment addresses the orthodontics market. The Company has a network of approximately 240 orthodontists and general dentists across the United States, Puerto Rico, Canada, Australia and the United Kingdom. The Company provides customer care to its members through a variety of communication channels, including its Website, phone, chat, e-mail and social media. SmileCheck platform is a central data repository for all medical records, business transactions and member communications. SmileCheck provides online portal that allows for remote access to treatment plan information. The Company offers aligners, impression kits, whitening gel and retainers.

  • Revenue in USD (TTM)659.59m
  • Net income in USD-78.03m
  • Incorporated--
  • Employees4.00k
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
(YOY change %)
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
(5 yr growth rate)
Avanos Medical Inc715.10m-38.50m1.79bn5.38k--1.43511.212.50-0.8073-0.807314.9226.060.41912.225.40132,918.20-2.26-2.42-2.51-2.8450.6955.53-5.38-7.281.834.160.1226--2.477.03-13.94---22.10--
Lantheus Holdings Inc341.22m-7.80m1.82bn595.00--3.4585.675.34-0.1761-0.17615.587.830.5476.216.57573,470.60-1.256.05-1.396.9644.3747.97-2.297.432.140.90520.2560.00-2.282.95-142.55---1.05--
BioLife Solutions Inc52.77m-20.76m1.90bn193.00--7.57--35.96-0.8372-0.83721.746.210.3152.105.59273,430.10-12.39-12.25-14.16-13.2755.2362.13-39.34-30.196.40--0.0128--75.6949.45260.95--40.67--
Outset Medical Inc65.66m-112.74m1.97bn313.00--5.98--29.95-2.63-2.631.517.150.22995.306.89209,779.50-45.82---51.17---13.99---199.31--8.53-59.480.0883--231.18--7.18------
Butterfly Network Inc12.44m-132.89m2.10bn260.00--4.82--169.11-2.64-2.640.19382.280.0384----47,857.69-41.03---44.66--51.56---1,068.02--10.87-0.7510.00--------------
Glaukos Corp237.59m-82.76m2.28bn653.00--3.83--9.58-1.85-1.855.2812.820.26363.537.25363,845.30-9.18-6.01-11.69-6.6068.0978.99-34.83-12.371.37-5.370.3657---5.0725.69-880.26---15.27--
Heska Corp227.17m-7.24m2.60bn602.00--6.12368.1411.46-0.8371-0.837124.6340.820.49363.919.66377,363.80-1.451.98-1.552.3541.0843.08-2.932.587.500.00840.1662--60.8713.54-882.87---28.89--
SmileDirectClub Inc659.59m-78.03m2.67bn4.00k--12.09--4.04-0.5184-0.51843.650.56920.70926.872.79164,897.80-28.68---34.12--70.43---40.44--3.92-1.970.9029---12.48--31.57------
Fulgent Genetics Inc773.39m416.96m2.76bn429.006.413.446.553.5714.8514.8529.7327.651.42--6.921,802,769.0076.6633.2594.1738.1279.3374.6653.9439.63----0.01840.001,196.46113.1952,243.55--75.67--
Adapthealth Corp1.36bn-165.44m2.86bn8.70k--1.60--2.10-2.46-2.4619.2913.820.525423.657.18156,476.50-7.64---8.82--18.83---14.54--0.83410.74730.4992--102.15---657.38------
Patterson Companies, Inc.5.91bn155.98m2.97bn7.80k19.013.0812.700.50261.611.6161.159.952.166.0813.66757,957.205.67-0.34759.40-0.49220.3521.732.62-0.19960.806819.730.3993--7.691.88126.51-3.43-20.132.93
Axonics Inc119.61m-62.80m3.03bn416.00--8.47--25.33-1.64-1.643.117.890.36121.075.66287,528.80-18.96---20.31--59.43---52.50--6.53-42.520.1855--707.06--31.30------
Haemonetics Corporation870.46m79.47m3.04bn2.71k38.434.1418.553.491.551.5517.0214.380.56401.595.95321,441.305.153.926.214.9145.7546.029.135.591.466.040.49160.00-11.94-0.8593.85---18.40--
Integer Holdings Corp1.04bn67.68m3.26bn7.50k48.362.5522.,064.402.852.293.082.4726.4129.446.545.191.582.710.34970.00-14.686.05-15.30--2.89--
NuVasive, Inc.1.06bn-49.96m3.38bn2.70k--4.0236.543.18-0.9763-0.976320.6516.260.48431.005.42393,314.80-2.281.55-2.961.8169.7272.62-4.702.572.070.62340.51330.00-10.065.31-156.95--0.3312--
Owens & Minor, Inc.8.68bn166.57m3.41bn6.30k18.524.3413.190.39312.451.54131.5310.472.445.9512.371,378,416.004.69-1.107.90-1.8016.7612.651.92-0.39480.66095.190.5552---7.93-2.80489.98-2.9910.08-60.27
Data as of Jul 28 2021. Currency figures normalised to SmileDirectClub Inc's reporting currency: US Dollar USD

Institutional shareholders

36.15%Per cent of shares held by top holders
HolderShares% Held
Victory Capital Management, Inc. (Investment Management)as of 31 Mar 20218.46m7.16%
The Vanguard Group, Inc.as of 31 Mar 20218.24m6.97%
Frontier Capital Management Co. LLCas of 31 Mar 20217.03m5.95%
Fidelity Management & Research Co. LLCas of 31 Mar 20214.39m3.72%
683 Capital Management LLCas of 31 Mar 20213.31m2.80%
Royce & Associates LPas of 31 Mar 20213.00m2.53%
Morgan Stanley & Co. LLCas of 31 Mar 20212.30m1.95%
Citadel Advisors LLCas of 31 Mar 20212.09m1.77%
Millennium Management LLCas of 31 Mar 20212.05m1.73%
Integrated Investment Consultants LLCas of 30 Jun 20211.87m1.58%
More ▼
Data from 31 Mar 2021 - 30 Jun 2021Source: FactSet Research Systems Inc.
Refinitiv, an LSEG business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.